Shuling Wu
Impact in
- Dermatology top 5%
- Skin Protection and Aging
- Endocrinology top 10%
- Infections and bacterial resistance
Papers in
-
- Acute Lymphoblastic Leukemia research 10
-
- Traditional Chinese Medicine Analysis 3
- Medical Research and Treatments 2
- Co-authors
- Beate Tebbe (2 shared papers)Constantin E. Orfanos (2 shared papers)Reinhard V. Gessner (6 shared papers)Christoph C. Geilen (2 shared papers)Vitam Kodelja (1 shared paper)Jürgen Eberle (1 shared paper)Guenter Henze (4 shared papers)Karl Seeger (4 shared papers)
In The Last Decade
Shuling Wu
29 papers receiving 579 citations
Peers
Comparison fields: 5 of 71
- Dermatology 80
- Endocrinology 39
- Internal Medicine 22
- Aging 7
- Drug Discovery 1
Countries citing papers authored by Shuling Wu
This map shows the geographic impact of Shuling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuling Wu more than expected).
Fields of papers citing papers by Shuling Wu
This network shows the impact of papers produced by Shuling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuling Wu. The network helps show where Shuling Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuling Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 101 | |
| 2 | 2011 | 48 | |
| 3 | 2016 | 45 | |
| 4 | 2005 | 44 | |
| 5 | 2000 | 39 | |
| 6 | 2001 | 38 | |
| 7 | 2008 | 38 | |
| 8 | 2015 | 32 | |
| 9 | 2009 | 31 | |
| 10 | 2016 | 28 | |
| 11 | 2000 | 24 | |
| 12 | 2005 | 22 | |
| 13 | 2006 | 18 | |
| 14 | 2004 | 17 | |
| 15 | 2020 | 16 | |
| 16 | 2018 | 12 | |
| 17 | 2019 | 12 | |
| 18 | 2020 | 12 | |
| 19 | 2003 | 7 | |
| 20 | 2021 | 6 |
About Shuling Wu
Shuling Wu is a scholar working on Public Health, Environmental and Occupational Health, Complementary and alternative medicine, Internal Medicine, Molecular Medicine and Dermatology, having authored 29 papers that have together received 612 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (10 papers), Traditional Chinese Medicine Analysis (3 papers), Pneumonia and Respiratory Infections (2 papers), Fungal Biology and Applications (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Skin Protection and Aging (2 papers), Medical Research and Treatments (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Dermatology (80 citations), Endocrinology (39 citations), Internal Medicine (22 citations), Aging (7 citations) and Drug Discovery (1 citation). Shuling Wu has collaborated with scholars based in Germany, China and Taiwan. Frequent co-authors include Beate Tebbe, Constantin E. Orfanos, Reinhard V. Gessner, Christoph C. Geilen, Vitam Kodelja, Jürgen Eberle, Guenter Henze, Karl Seeger, Arend von Stackelberg and Deng‐Chyang Wu. Their work appears in journals such as Cancer, Blood, Cytokine, Frontiers in Medicine and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.